[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:paranasal-sinus-squamous-cell-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Paranasal Sinus Squamous Cell Carcinoma",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05027633","Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity \u002F Paranasal Sinuses (I-NAPA)",[11],"Phase 2","RECRUITING","2026-08-26T02:19:14.560989Z","2026-05-05T02:43:27.754928Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05172245","Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer",[19],"Phase 1","2026-08-26T02:17:41.695983Z","2026-07-19T19:36:05.120891Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT07156227","Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma",[19],"2026-08-26T02:17:44.240289Z","2026-06-04T01:30:07.902043Z",[],[]]